Table Of Content

DRUG and ALCOHOL DEPENDENCE Drug and Alcohol Dependence 70 (2003) 333-335 www.elsevier.com/locate/drugaledep Volume contents Volume 70 (2003) Volume 70/1 Full length reports The influence of partner drug use and relationship power on treatment engagement K.S. Riehman, M.Y. Iguchi, M. Zeller, A.R. Morral Inhaled drugs of abuse enhance serotonin-3 receptor function G.F. Lopreato, R. Phelan, C.M. Borghese, M.J. Beckstead, S.J. Mihic Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and 8-funaltrexamine S.S. Negus, M.R. Brandt, M.B. Gatch, N.K. Mello Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study C.A. Dackis, K.G. Lynch, E. Yu, F.F. Samaha, K.M. Kampman, J.W. Cornish, A. Rowan, S. Poole, L. White, C.P. O’Brien Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys S.S. Negus, N.K. Mello Arrests and convictions for cannabis related offences in a New Zealand birth cohort D.M. Fergusson, N.R. Swain-Campbell, L.J. Horwood An examination of indirect risk of exposure to HIV among wives of substance-abusing men W. Fals-Stewart, G.R. Birchler, C. Hoebbel, T.B. Kashdan, J. Golden, K. Parks..................ccccccssccsssscssessesscscsoressssesssesseceneccsessssoesensosessesee Role of catalase in ethanol-induced conditioned taste aversion: a study with 3-amino-1,2,4-triazole E. Quertemont, M.D. Escarabajal, P. De Witte Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study F. Caputo, G. Addolorato, F. Lorenzini, M. Domenicali, G. Greco, A. del RE, G. Gasbarrini, G.F. Stefanini, M. Bernardi Screening for sexually transmitted infections in substance abuse treatment programs J.M. Liebschutz, E.P. Finley, P.G. Braslins, D. Christiansen, N.J. Horton, J.H. Samet Short communications Cocaine use disorders and suicidal ideation S.J. Garlow, D. Purselle, B. D’Orio Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats G. Colombo, S. Serra, G. Brunetti, G. Vacca, M.A.M. Carai, G.L. Gessa Publisher’s Acknowledgement re 0 i ambceba inh capelb deib lige dealiamaAMiphaslaunnuahedindaibshkeks abv iaieubaitagnsninsebandaasitcesqothspissasanensininelepindineeenien Volume 70/2 Review article Single versus multiple drug focus in substance abuse clinical trials research B.J. Rounsaville, N.M. Petry, K.M. Carroll Commentaries Transporting efficacious treatments from academia to community: barriers and opportunities A.J. Saxon Single versus multiple drug focus in substance abuse clinical trials research: the devil is in the details E.C. Strain Can we design and replicate clinical trials with a multiple drug focus C.P. O’Brien, K.G. Lynch doi:10.1016/S0376-87 16(03)00151-0 334 Volume contents Full lenth reports Income distribution and risk of fatal drug overdose in New York City neighborhoods S. Galea, J. Ahern, D. Vlahov, P.O. Coffin, C. Fuller, A.C. Leon, K. Tardiff The effects of escalating doses of smoked cocaine in humans Ac an, PII: Sic UNNI Scchl linc PENNY RUG MEI IIIUDD ccs dnndcacosestickesictadsissadadbacecestuenaselhioustinsensndebecensennsiatonioedeitchngedbbvinseheinebinscdeecciesteuts Injection frequency mediates health service use among persons with a history of drug injection M.D. Stein, B. Anderson A tripartite of HIV-risk for African American women: the intersection of drug use, violence, and depression S.D. Johnson, R.M. Cunningham-Williams, L.B. Cottler Screening for cannabis use disorders in an adolescent emergency department sample T. Chung, $.M. Colby, T.A. O'Leary, N.P. Barnett, P.M. Monti Smoking and substance abuse in outpatients with schizophrenia: a 2-year follow-up study in Turkey O. Uzun, A. Cansever, C. Basoglu, A. Ozsahin Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment J. Esteban, C. Gimeno, J. Barril, A. Aragonés, J.M. Climent, M. de la Cruz Pellin Alcohol outcome expectancies and risk for alcohol use problems in women with and without a family history of alcoholism etn MW Ns A ges kk 1 ois acestl asedeniion halosb ebehuenbc peda saiebaiiaamrebbdessDbaaiadebbicadddbueaitaiudinndiaainaddiniaietcaniimdasdainintlet ™ Short communication Preliminary study on reducing oral moist snuff use D.K. Hatsukami, A. Edmonds, S. Schulte, J. Jensen, C.T. Le, L. Losey, $.G. Carmella, $.S. Hecht Cir ee Cis ciiscncoccssiuanernadiiniedheinaincasaicccsssetscsnsceshestesidincensouanncnibissmnsuenssoratteveeudabaneisatniesedienvebestuasuestiaineniewscanmseiieonsubsiahuubles Volume 70/2 Supplement Foreword to: Buprenorphine and buprenorphine/naloxone: a guide for clinicians P.J. Fudala, T.P. Bridge From morphine clinics to buprenorphine regulating opoid agonist treatment of addiction in the United States J.H. Jaffe, C. O'Keeffe The clinical pharmacology of buprenorphine extrapolating from the laboratory of the clinic S.L. Walsh, T. Eisenberg Clinical and pharmacological evaluation of buprenorphine and naloxone combination: why the 4:1 ratio for treatment? Fe Rs Sei Se cttcvccthtictblesei akapnidetsthabckatsiiapiadbidplaaainntntiaddssatnsssucennesanbisn saaphucdheisiaphnacebeeianibabsdasitaensbtebcihuangbentibecbanadiecssnsseadnsmaececssaid ath Pharmacokinetics of the combination tablet of buprenorphine and naloxone ape UTE sh IIIT sss sca caceastaaleladuaieeindiide uhcagtea tanks debldgapaidabanbbemuconesanstédggninsaddbsabeinesyubnniuinntnabrevedadsiansssdyendischenisensbondsababshineibadsneeabio’ Clinical efficacy of buprenorphine comparisons to methadone and placebo W. Ling, D.R. Wesson Buprenorphine: how to use it right es Sees: Tela: CEIEENG: Mii SIMI ‘nhniiensnncdsnocnsnntiicasecsesnnthdansdnhsceeneuineunceduisenhdekuninecentinlinsesaibeksehhebbontinhaanebidehich shiuiihebeigepnaatallinipeanantnbinihipeednpianis Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment foropiate dependence T.P. Bridge, P.J. Fudula, S. Herbert, D.B. Leiderman Use of buprenorphine in pregnancy: patient management and effects on the neonate R.E. Johnson, H.E. Jones, G. Fischer Accessing opiate-dependence treatment medications: buprenorphine products in an office-based setting A.1. Leshner Volume 70/3 Review article Treatment of adolescent tobacco smokers: issues and opportunities for exposure reduction approaches E.T. Moolchan, A.T. Aung, J.E. Henningfield Full length reports Behavioral and subjective effects of marijuana following partial sleep deprivation A. Liguori, C.P. Gatto, D.B. Jarrett, W. Vaughn McCall, T.W. Brown Recanting of substance use reports in a longitudinal prevention study M. Fendrich, D.P. Rosenbaum Discriminative stimulus effects of (—)-ephedrine in rats: analysis with catecholamine transporter and receptor ligands L.R. McMahon, K.A. Cunningham A pilot trial of olanzapine for the treatment of cocaine dependence K.M. Kampman, H. Pettinati, K.G. Lynch, T. Sparkman, C.P. O’Brien Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia L. Topp, C. Day, L. Degenhardt Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration study N. Lintzeris, G. Bammer, L. Rushworth, D.J. Jolley, G. Whelan